PROFICIA

Serial Number 76588965
Registration 3031150
800

Registration Progress

Application Filed
Apr 27, 2004
Under Examination
Sep 27, 2005
Approved for Publication
Jun 15, 2005
Published for Opposition
Jul 5, 2005
Registered
Dec 20, 2005

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20051220) (Grace Period Filing)
Due: Jun 20, 2026 Grace Period - 174 days
Original deadline was Dec 20, 2025 (overdue)

Trademark Image

PROFICIA

Basic Information

Serial Number
76588965
Registration Number
3031150
Filing Date
April 27, 2004
Registration Date
December 20, 2005
Published for Opposition
July 5, 2005
Renewal Date
December 20, 2015
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Mar 3, 2016
Registration
Registered
Classes
042

Rights Holder

Medicago Inc.

03
Address
4100-1155, boulevard René-Lévesque Ouest
Montréal (Québec) H3B3V2
CA

Ownership History

Medicago Inc.

Original Applicant
03
Sainte-Foy (Quebec) G1V 3V9 CA

Medicago Inc.

Owner at Publication
03
Sainte-Foy (Quebec) G1V 3V9 CA

Medicago Inc.

Original Registrant
03
Montréal (Québec) CA

Legal Representation

Attorney
Benjamin M. Cantor

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20051220)
Due Date
December 20, 2025
Grace Period Ends
June 20, 2026

Application History

37 events
Date Code Type Description Documents
Dec 20, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Feb 2, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 2, 2024 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Loading...
Feb 2, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 2, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 2, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 2, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 11, 2019 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Jul 11, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 19, 2019 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Mar 3, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Mar 3, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Mar 3, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Mar 3, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Dec 18, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Sep 24, 2012 CORV 2 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS NOT UPDATED Loading...
Sep 13, 2012 MAIL I PAPER RECEIVED Loading...
Jun 18, 2011 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 13, 2011 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 11, 2011 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 20, 2005 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 9, 2005 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Nov 9, 2005 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Oct 25, 2005 MAIL I PAPER RECEIVED Loading...
Sep 27, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 5, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 15, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Mar 31, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 25, 2005 ALIE A ASSIGNED TO LIE Loading...
Mar 21, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 18, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Mar 7, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2005 MAIL I PAPER RECEIVED Loading...
Nov 23, 2004 CNSL F LETTER OF SUSPENSION MAILED Loading...
Nov 22, 2004 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 21, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
May 13, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of a proprietary recombinant protein platform technologies designed to lead to new pharmaceutical products namely-- vaccines, antibiotics, antiviral, anti-inflammatory, anti-infectives, anti-fungals, antiprurities, cardiovascular agents, hormones, antineoplastics, anti-cancer, antipsychotics, anti-anginals, anti-thrombotics, anti-arrhythmia and anti-hypertensives

Additional Information

Other
The drawing is amended to appear as follows: PROFICIA; and in the statement, the standard character statement is inserted.

Classification

International Classes
042